¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

½ÉÀå´ë»çÁõÈıºÇÐȸ 2024 7th APCMS (Asia-Pacific CardioMetabolic Syndrome) CONGRESS (2ÀÏÂ÷) : 2024-04-27

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

½ÉÀå´ë»çÁõÈıºÇÐȸ 2024 7th APCMS (Asia-Pacific CardioMetabolic Syndrome) CONGRESS (2ÀÏÂ÷) : 2024-04-27
±³À°ÀÏÀÚ : 2024-04-27
±³À°Àå¼Ò : Conrad Hotel Seoul (5F PARK BALLROOM)

±³À°ÁÖÁ¦ : 2024 7th APCMS (Asia-Pacific CardioMetabolic Syndrome) CONGRESS (2ÀÏÂ÷)

ÁÖÃÖ±â°ü : ´ëÇѽÉÀåÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ½ÉÀå´ë»çÁõÈıºÇÐȸ

´ã´çÀÚ : ±è¼±¿Á
¿¬¶ôó : 02-717-8977

À̸ÞÀÏ : apcms@kscms.org

±³À°Á¾·ù : ³»°ú

Âü¼®¿¹»óÀÎ : 200¸í
Èñ¸ÁÆòÁ¡ : 6Á¡

Áö¿ª : ¼­¿ïƯº°½Ã
±³À°½Ã°£ : 16 ½Ã°£ 20ºÐ

¼¼ºÎ¼ö°­·á : 140,000¿ø  

ºñ°í Àü¹®ÀÇ,±³¼ö: ȸ¿ø 120000, ºñȸ¿ø 140000 ÀüÀÓÀÇ,Àü°øÀÇ,±ºÀÇ°ü,°øº¸ÀÇ,¿¬±¸¿ø,°£È£»ç,¿µ¾ç»ç,¾à»ç,±â¾÷ȸ¿ø,±âŸ: 60000


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 04¿ù 27ÀÏ Room 1 08:30~08:45 Potential Mechanism of SGLT2i in HF À̼ö¿ë(ºÎ»êÀÇ´ë ¼øȯ±â³»°ú)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 1 08:45~09:00 Metabolic Reprogramming of SGLT2i in Isolated Perfusion Hearts ¹ÚÈÆÁØ(°¡Å縯ÀÇ´ë ¼øȯ±â³»°ú)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 1 09:00~09:15 Effects of SGLT2i on Afib and Stroke ÃÖ¿µ(°¡Å縯ÀÇ´ë ¼øȯ±â³»°ú)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 1 09:15~09:30 Efficacy of SGLT2 Inhibitors with Different SGLT1/SGLT2 Selectivity in CV Outcomes ÀÌÀºÁ¤(¼º±Õ°üÀÇ´ë ³»ºÐºñ³»°ú)

Åä·Ð 04¿ù 27ÀÏ Room 1 09:30~09:50 Discussion ¼­Á¸(¼øõÇâÀÇ´ë ½ÉÀå³»°ú)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 1 14:40~14:50 (Abstract) Foxm1-Mediated Mitochondrial Function In Cardiomyocytes Protects Cardiac Ischemic Injury Through Suppressing Mkrn1-Dependent LKB1 Ubiquitination Shuai Song(Zhongshan Hospital, Fudan University)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 1 14:50~15:00 (Abstract) Ketogenic Diet Protects Cardiac Lipid Deposit And Inflammation in Advanced Cardiac Aging in A GIP-dependent Fashion Yasuko K Bando(Mie Univ. Graduate School of Medicine)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 1 15:00~15:10 (Abstract) Association of lipoprotein(a) with NAFLD and MAFLD °­Á¤±Ô(¼º±Õ°üÀÇ´ë)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 1 15:10~15:20 (Abstract) Effect of Yoga Therapy on Disease Activity, Inflammatory Markers and Heart Rate Variability in Patients with Osteoarthritis Knee Patients Vandana Awasthi(King George)

Åä·Ð 04¿ù 27ÀÏ Room 1 15:20~15:30 Discussion ±è´Ù·¡(¼º±Õ°üÀÇ´ë ¼øȯ±â³»°ú)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 1 15:40~15:55 Evolving Perspectives: 2022 Updates in Korean Hypertension Guidelines ±èÇзÉ(¼­¿ïÀÇ´ë ¼øȯ±â³»°ú)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 1 15:55~16:10 Digital Therapeutics for Hypertension: Maximizing the Effects of Lifestyle Modification Akihiro Nomura(Kanazawa Univ.)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 1 16:10~16:25 Evidence and Perspective of Out-of-office Blood Pressure in Japan Satoshi Hoshide(Jichi Medical Univ. School of Medicine)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 1 16:25~16:40 Empowering Health: The Vital Role of Patient Education in Managing Hypertension and Cardiometabolic Syndrome in Korea ±èÇöÁø(ÇѾçÀÇ´ë ½ÉÀå³»°ú)

Åä·Ð 04¿ù 27ÀÏ Room 1 16:40~17:00 Discussion ¹Ú»ó¹Î(À»ÁöÀÇ´ë ¼øȯ±â³»°ú)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 2 08:30~08:45 Recent Advances in the Pathogenesis of NAFLD ÀÌ¿µ¼±(°í·ÁÀÇ´ë ¼ÒÈ­±â³»°ú)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 2 08:45~09:00 NAFLD, Diabetes, and CVD ÇÑÀ¯Áø(°è¸íÀÇ´ë ³»ºÐºñ³»°ú)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 2 09:00~09:15 NAFLD and Cardiometabolic Syndrome: Exploring the Role of Liver Fibrosis ÀÌÇý¿ø(¿¬¼¼ÀÇ´ë ¼ÒÈ­±â³»°ú)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 2 09:15~09:30 Targeting Treatment in NAFLD ¹ÚÁ¤È¯(ÇѾçÀÇ´ë ³»ºÐºñ³»°ú)

Åä·Ð 04¿ù 27ÀÏ Room 2 09:30~09:50 Discussion À¯¼öÁ¾(¼­¿ïÀÇ´ë ¼ÒÈ­±â³»°ú)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 2 14:40~14:50 (Abstract) Deep Learning Analysis of Ocular Biomarkers for Early Prediction of Cardiometabolic Syndrome Using Optical Coherence Tomography Rifaldy Fajar(Karlstad University)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 2 14:50~15:00 (Abstract) Eligibility and cost-utility analysis of dapagliflozin in patients with heart failure across the whole spectrum of ejection fraction in South Korea À±Á¾Âù(°¡Å縯ÀÇ´ë ¼øȯ±â³»°ú)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 2 15:00~15:10 (Abstract) Proof Extraction from Medical Guidelines Using Chain of Reasoning for Cardiac Patient Assessment Ubaid Ur Rehman(Kyung Hee University)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 2 15:10~15:20 (Abstract) Cardiovascular health status of people with elevated lipoprotein(a) identified via a cascade testing program: opportunity for prevention Dick Chi Chan(University of Western Australia)

Åä·Ð 04¿ù 27ÀÏ Room 2 15:20~15:30 Discussion ÁÖÇüÁØ(°í·ÁÀÇ´ë ¼øȯ±â³»°ú)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 2 15:40~16:00 Understanding TRL and TG Metabolism and Its Relationship with Cardiovascular Risk ÀÌ»óÇÐ(¿¬¼¼ÀÇ´ë ½ÉÀå³»°ú)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 2 16:00~16:20 Remnant Cholesterol and Atherosclerotic Cardiovascular Disease ±è³²ÈÆ(°í·ÁÀÇ´ë ³»°ú)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 2 16:20~16:40 TG-lowering Therapy Strategies in the Statin Era Á¶»óÈ£(ÇѸ²ÀÇ´ë ½ÉÀå³»°ú)

Åä·Ð 04¿ù 27ÀÏ Room 2 16:40~17:00 Discussion ¹Î¼¼Èñ(¿ï»êÀÇ´ë ³»ºÐºñ³»°ú)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 2 17:10~17:20 (Abstract) The adiponectin receptor agonist ALY688 prevents pressure overload-induced heart failure with reduced ejection fraction (HFrEF). Sungji Cho(York University)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 2 17:20~17:30 (Abstract) Comparative Efficacy of of High-Dose Rosuvastatin and Atorvastatin in Preventing Cystatin C-Oriented Contrast-induced Nephropathy in Statin-naïve Patients with Acute Myocardial Infarction:From the RACCOON study ±èÁöÇý(ÃæºÏÀÇ´ë)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 2 17:30~17:40 (Abstract) Transcriptomic Analysis Illustrates Unique Metabolic Characteristics Of Activated Cardiac Fibroblasts In Experimental Myocardial Infarction. Zihang Huang(Zhongshan Hospital, Fudan University)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 2 17:40~17:50 (Abstract) Is usage of mobile phones disrupting sleep in Patients with Metabolic Syndrome? A Comparative Study on Artificial Light at night (ALAN) Light Pollution as a Zeitgeber Smriti Rastogi(King George)

Åä·Ð 04¿ù 27ÀÏ Room 2 17:40~17:50 Discussion À±Á¾Âù(°¡Å縯ÀÇ´ë ¼øȯ±â³»°ú)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 3 08:30~08:45 Perspective on Diagnostic Methods and Criteria for Obesity ±èº¸¿¬(¼øõÇâÀÇ´ë ³»ºÐºñ³»°ú)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 3 08:45~09:00 Obesity Related Cardiometabolic Disorders ±èÇý¹Ì(Áß¾ÓÀÇ´ë ¼øȯ±â³»°ú)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 3 09:00~09:15 Obesity Paradox in Heart Diseases Á¤¹ÌÇâ(°¡Å縯ÀÇ´ë ¼øȯ±â³»°ú)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 3 09:15~09:30 Obesity and Sleep Disorder Alice PS Kong(Hong Kong SAR, China)

Åä·Ð 04¿ù 27ÀÏ Room 3 09:30~09:50 Discussion ¼­¹ÌÇý(¼øõÇâÀÇ´ë ³»ºÐºñ³»°ú)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 3 13:00~13:20 Cardiovascular Complications in Chronic Kidney Disease: Mechanisms and Clinical Implications À§Áø(°¡ÃµÀÇ´ë ½ÉÀå³»°ú)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 3 13:20~13:40 Lifestyle Intervention for the Prevention and Treatment of CMS-related Kidney Disease ±Ç¼ÒÀÌ(Áß¾ÓÀÇ´ë ½ÅÀå³»°ú)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 3 13:40~14:00 Pharmacological Interventions for CMS and Kidney Disease ¼ÕÇüÀº(Áß¾ÓÀÇ´ë ½ÅÀå³»°ú)

Åä·Ð 04¿ù 27ÀÏ Room 3 14:00~14:20 Discussion ¼­Àçºó(¼­¿ïÀÇ´ë ¼øȯ±â³»°ú)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 3 14:30~14:45 Introduction of Lp(a) Florian Kronenberg(Medical Univ. of Innsbruck)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 3 14:45~15:00 Genetic Epidemiologic Evidence for Lp(a) Pia R. Kamstrup(Copenhagen Univ. Hospital – Herlev Gentofte)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 3 15:00~15:15 Current Status and Perspectives of Lp(a) Treatment Stephen J. Nicholls(Monash Health)

Åä·Ð 04¿ù 27ÀÏ Room 3 15:15~15:30 Discussion Á¶°æÈÆ(Àü³²ÀÇ´ë ¼øȯ±â³»°ú)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 3 15:40~15:55 Induction of KLF2 by Exercise Activates eNOS to Improve Endothelial Function in Diabetic Mice Yu Huang(City Univ. of Hong Kong)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 3 15:55~16:10 Roles of CHIP Ubiquitin Ligase in Steatohepatitis ¿ìâÈÆ(¿µ³²ÀÇ´ë ¾à¸®Çб³½Ç)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 3 16:10~16:25 Atheroslerosis-promoting Effect of Porphyrimonas Gingivalis Infection ¹Ú¿µ¹Ì(ÀÌÈ­ÀÇ´ë ºÐÀÚÀÇÇб³½Ç)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 3 16:25~16:40 Cellular Senescence Promotes Pathogenesis in Cardiovascular-metabolic Diseases Ippei Shimizu (National Cerebral and Cardiovascular Center)

Åä·Ð 04¿ù 27ÀÏ Room 3 16:40~17:00 Discussion ÃÖ¿¬Á÷(°¡Å縯ÀÇ´ë ¼øȯ±â³»°ú)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 1+2 13:00~13:30 Implication of Sarcopenia in Cardiometabolic Health Hidenori Arai (National Center for Geriatrics and Gerontology)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 1+2 13:30~14:00 When Being Lean is Not Enough: The Metabolically-unhealthy Normal-weight Phenotype and Cardiometabolic Disease Faidon Magkos (Univ. of Copenhagen)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 1+2 14:00~14:30 Cross-sectional Analysis of AMI Patients of Korea and Chinese Xian Wu Cheng (Yanbian Univ. Hospital)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 1+2+3 10:00~10:30 Beyond the Myths: The Realities of HyperTG on Cardiovascular Outcomes ÇѽÂȯ(President of the KSCMS & APCMS)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 1+2+3 10:30~11:00 Vascular Lipid Metabolism in Atherosclerosis William A. Boisvert(Univ. of Hawaii School of Medicine)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 1+2+3 11:00~11:30 Unveiling the Roles of Peroxiredoxins in Cardiovascular Pathologies: A Comprehensive Exploration ¿À±¸ÅÃ(ÀÌÈ­¿©´ë »ý¸í°úÇаú)

±³À°½Ã°£ 04¿ù 27ÀÏ Room 1+2+3 11:30~12:00 Should Dyslipidemia Guidelines Be Changed in Statins Era? °í±¤°ï(K Heart Clinic)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ½ÉÀå´ë»çÁõÈıºÇÐȸ 2024 7th APCMS (Asia-Pacific CardioMetabolic Syndrome) CONGRESS (2ÀÏÂ÷) : 2024-04-27""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2024³âµµ ´ëÇѽŰæ°úÇÐȸ ÅëÁõ ½Ç±â ¿öÅ©¼ó : 2024-04-28
´ÙÀ½±Û ´ëÇѺñ´¢»ý½Ä¿µ»óÀÇÇÐȸ Á¦21ȸ Á¤±âÇмú´ëȸ : 2024-04-27
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
20613 ´ë±¸ ´ëÇѽºÆ÷Ã÷ÀÇÇÐȸ Sports Medicine Symposium 2024 in Daegu : 2024-06-23 0 0 2024-04-29
20612 ¼­¿ï 2024³â ´ëÇÑ°ñ´ë»çÇÐȸ Á¦12Â÷ Clinical Densitometry Course : 2024-06-23 0 1 2024-04-29
20611 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 1Â÷(2ÀÏÂ÷) : 2024-06-22 0 0 2024-04-29
20610 ¼­¿ï ¼­¿ï¾Æ»êº´¿ø (¿Â¶óÀÎ) 6¿ù 21ÀÏ ±Ý¿äÁý´ãȸ(ÀÌ°ü ÁúȯÀÇ Áø´Ü°ú Ä¡·á) : 2024-06-21 0 1 2024-04-29
20609 °æ±â ¾È»ê ¹× ½ÃÈ­Áö¿ª À̺ñÀÎÈÄ°ú Àǻ縦 À§ÇÑ Áý´ãȸ(¾È¸é¸¶ºñ) : 2024-06-21 0 0 2024-04-29
20608 ¼­¿ï 2024³â ü°èÀû ¹®Çå°íÂû(¸ÞŸºÐ¼®) ³í¹®Ãâ°£ ¿öÅ©¼¥ 1Â÷(1ÀÏÂ÷) : 2024-06-21 0 1 2024-04-29
20607 ¼­¿ï 2024 ´ëÇÑȯ°æõ½ÄÆóÁúȯÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-21 0 0 2024-04-29
20606 ¼­¿ï (¿Â¶óÀÎ)À̺ñÀÎÈÄ°ú Áö¿ªÀÇ»çÁý´ãȸ-¿Ü·¡¿¡¼­ °£´ÜÇÏ°Ô ÇÒ ¼ö ÀÖ´Â À½¼ºÄ¡·á : 2024-06-20 0 2 2024-04-29
20605 ´ë±¸ ´ëÇÑ»êºÎÀΰúÇÐȸ ´ë±¸Áöȸ ¿¬¼ö°­Á : 2024-06-20 0 1 2024-04-29
20604 °­¿ø Á¦171ȸ ÇѸ²´ëÇб³Ãáõ¼º½Éº´¿ø ¼ÒÈ­±â ¿¬¼ö±³À° : 2024-06-19 0 0 2024-04-29
20603 °æ±â Á¦16ȸ ±¹¸³¾Ï¼¾ÅÍ ±¹Á¦½ÉÆ÷Áö¾ö : 2024-06-19 0 2 2024-04-29
20602 ¼­¿ï ´ëÇѽÅÀåÇÐȸ APCN & KSN 2024 4ÀÏÂ÷ : 2024-06-16 0 5 2024-04-29
20601 ¼­¿ï [¿Â¶óÀÎ] Áø´Ü¿ë ¹æ»ç¼± ¾ÈÀü°ü¸®Ã¥ÀÓÀÚ ¼±ÀÓ±³À° : 2024-06-16 0 1 2024-04-29
20600 ¼­¿ï 2024 Á¦ 2ȸ ¿¬¼¼´ëÇб³ ¼öºÎ ¹× »óÁö ½ÉÆ÷Áö¾ö : 2024-06-16 0 0 2024-04-29
20599 ¼­¿ï ´ëÇÑ»êºÎÀΰú³»ºÐºñÇÐȸ ¿¬¼ö°­Á : 2024 »êºÎÀΰú¹Ì¼º³â¿¬¼ö°­Á : 2024-06-16 0 0 2024-04-29
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷